Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Correction

Accepted on 05 Sep 2025

Correction: Editorial: Current status and recent advances in preclinical models for rare cancers

in Cancer Molecular Targets and Therapeutics

Ewa Krawczyk
Luciane R Cavalli
Joanna Kitlinska

Frontiers in Oncology

doi 10.3389/fonc.2025.1697286

168 views

Review

Published on 05 Sep 2025

Application and development of Organ-on-a-Chip technology in cancer therapy

in Cancer Molecular Targets and Therapeutics

Ling xiao Wang
Shu ling Liu
Ning Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1643230

472 views

Original Research

Accepted on 04 Sep 2025

Mechanistic studies of miR-582-3p targeting of PTPRCAP affecting lung adenocarcinoma via the Wnt/β-catenin pathway

in Cancer Molecular Targets and Therapeutics

Yuting Yang
Song Zhao
Xiaoli Han
Pengfei Guo
Baoshan Zhao
Zongying Liang

Frontiers in Oncology

doi 10.3389/fonc.2025.1652176

247 views

Original Research

Published on 04 Sep 2025

Dynamic alterations in m6A RNA methylation profiles during involution of infantile hemangiomas

in Cancer Molecular Targets and Therapeutics

Pinru Wu
Qingqing Cen
Ying Shang
Junyan Liang
Gang Ma

Frontiers in Oncology

doi 10.3389/fonc.2025.1652621

971 views

Mini Review

Accepted on 03 Sep 2025

The Role of Apelin in Cancer

in Cancer Molecular Targets and Therapeutics

Yuki Agarwala
Rohini Sharma

Frontiers in Oncology

doi 10.3389/fonc.2025.1683865

268 views

Review

Published on 03 Sep 2025

Research on the function of GPX4 in tumor-targeted treatment based on its molecular structure and features

in Cancer Molecular Targets and Therapeutics

He Geng
Lin Ma
Lixin Wu
Cuicui Yao
Can Wang
Xinyan Gan
Yiyi Li
Fang Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1594234

1,140 views

Perspective

Accepted on 02 Sep 2025

Role and prognostic value of oncostatin M and its receptor OSMR in acute myeloid leukemia, myeloproliferative neoplasms and non-hematological malignancies

in Cancer Molecular Targets and Therapeutics

Jean-Pierre Levesque
Kavita Bisht
Kylie A Alexander
Ingrid Gabriele Winkler

Frontiers in Oncology

doi 10.3389/fonc.2025.1636570

212 views

Case Report

Published on 02 Sep 2025

Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literature

in Cancer Molecular Targets and Therapeutics

Christian R. Klein
Sebastian Koob
Verena Tischler
Annkristin Heine
Peter Brossart
Georg Feldmann
Karin Mayer

Frontiers in Oncology

doi 10.3389/fonc.2025.1626478

307 views

Original Research

Published on 01 Sep 2025

Evaluation of anti-liver cancer activity and anticancer mechanism of one novel small molecule compound (THY-10A62) targeting FAK pathway

in Cancer Molecular Targets and Therapeutics

Wanqiu Huang
Rong Zou
Jie Xu
Yuliang Deng
Dongping Zhang
Yiguo Hu
Qian Zhang
Jian Huang
Zhaoqi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1498005

396 views

Original Research

Published on 01 Sep 2025

MEX3A is a diagnostic, independent prognostic biomarker and a promising therapeutic target in glioblastoma

in Cancer Molecular Targets and Therapeutics

Francesca Bufalieri
Daniele Armocida
Antonino Cucinotta
Pietro Familiari
Laura Di Magno
Alessandra Serraino
Gennaro Adabbo
Francesca Agnoli
Ludovica Lospinoso Severini
Manila Antonelli

Frontiers in Oncology

doi 10.3389/fonc.2025.1585592

575 views

Original Research

Published on 01 Sep 2025

Diaryl pyrimidine guanidine suppresses hepatocellular carcinoma cell stemness by targeting β-catenin signaling

in Cancer Molecular Targets and Therapeutics

Xuechun Chen
Dongxuan Ni
Jinghui Cheng
Bin Liang
Ruihan Zhang
Weilie Xiao
Rong Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1641979

346 views

Original Research

Published on 28 Aug 2025

NK cell-related genes-driven novel molecular subtyping and prognostic signatures for Wilms tumor: uncovering the therapeutic potential of TGX-221 and biomarker role of HS2ST1

in Cancer Molecular Targets and Therapeutics

Peng Hong
Zaihong Hu
Jie Lin
Kongkong Cui
Zhiqiang Gao
Xiaomao Tian
Tao Lin
Qinlin Shi
Guanghui Wei

Frontiers in Oncology

doi 10.3389/fonc.2025.1593011

2,305 views

Mini Review

Published on 27 Aug 2025

TROP2: as a promising target in lung cancer

in Cancer Molecular Targets and Therapeutics

Xing-xing Li
Jia-li Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1569897

779 views

Editorial

Accepted on 26 Aug 2025

Editorial: RAS Inhibitor Therapy of Cancer

in Cancer Molecular Targets and Therapeutics

Donald Buchsbaum
Nicolas N Nassar
Gary Piazza

Frontiers in Oncology

doi 10.3389/fonc.2025.1685295

541 views

Original Research

Accepted on 26 Aug 2025

KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC

in Cancer Molecular Targets and Therapeutics

Alessandro Tubita
Sara Fancelli
Lorenzo Anela
Giulia Petroni
Enrico Caliman
Francesca Mazzoni
Federico Scolari
Brunella Napolitano
Beatrice Menicacci
Camilla Eva Comin

Frontiers in Oncology

doi 10.3389/fonc.2025.1654491

328 views

Editorial

Published on 26 Aug 2025

Editorial: Challenges and advances in carcinomatous meningitis treatment

in Cancer Molecular Targets and Therapeutics

Maciej M. Mrugala
Katherine B. Peters

Frontiers in Oncology

doi 10.3389/fonc.2025.1672755

1,165 views